307 related articles for article (PubMed ID: 10816544)
1. Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.
Hausman SZ; Burns DL
Infect Immun; 2000 Jun; 68(6):3763-7. PubMed ID: 10816544
[TBL] [Abstract][Full Text] [Related]
2. Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis.
Hausman SZ; Cherry JD; Heininger U; Wirsing von König CH; Burns DL
Infect Immun; 1996 Oct; 64(10):4020-6. PubMed ID: 8926063
[TBL] [Abstract][Full Text] [Related]
3. Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.
Williams MM; Sen K; Weigand MR; Skoff TH; Cunningham VA; Halse TA; Tondella ML;
Emerg Infect Dis; 2016 Feb; 22(2):319-322. PubMed ID: 26812174
[TBL] [Abstract][Full Text] [Related]
4. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
Munoz JJ; Peacock MG
Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
[TBL] [Abstract][Full Text] [Related]
5. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
6. Chick embryo, a model to study the lethal activity of pertussis toxin, infectivity of Bordetella pertussis, and their neutralization by immune sera.
Calver GA; Burton WW; Gardell CY
Can J Microbiol; 1993 Aug; 39(8):759-66. PubMed ID: 8106134
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs.
Stefanelli P; Mastrantonio P; Hausman SZ; Giuliano M; Burns DL
J Clin Microbiol; 1997 Jun; 35(6):1550-5. PubMed ID: 9163480
[TBL] [Abstract][Full Text] [Related]
8. [Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].
Shinkarev AS; Mertsalova NU; Mazurova IK; Borisova OIu; Zakharova NS; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Britsina MV; Bazhanova IG
Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):20-5. PubMed ID: 17886371
[TBL] [Abstract][Full Text] [Related]
9. The advent of recombinant pertussis vaccines.
Burnette WN
Biotechnology (N Y); 1990 Nov; 8(11):1002-5. PubMed ID: 1366927
[No Abstract] [Full Text] [Related]
10. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y
J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
[TBL] [Abstract][Full Text] [Related]
11. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
[TBL] [Abstract][Full Text] [Related]
12. Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.
Sukumar N; Sloan GP; Conover MS; Love CF; Mattoo S; Kock ND; Deora R
Infect Immun; 2010 May; 78(5):2008-16. PubMed ID: 20176797
[TBL] [Abstract][Full Text] [Related]
13. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.
Carbonetti NH; Artamonova GV; Andreasen C; Dudley E; Mays RM; Worthington ZE
Infect Immun; 2004 Jun; 72(6):3350-8. PubMed ID: 15155640
[TBL] [Abstract][Full Text] [Related]
14. Paradoxes of pertussis toxin.
Wardlaw AC
Zentralbl Bakteriol; 1990 May; 273(1):1-4. PubMed ID: 2194485
[No Abstract] [Full Text] [Related]
15. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
[TBL] [Abstract][Full Text] [Related]
16. Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica.
Walker MJ; Rohde M; Wehland J; Timmis KN
Infect Immun; 1991 Nov; 59(11):4238-48. PubMed ID: 1682257
[TBL] [Abstract][Full Text] [Related]
17. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens.
Stevenson A; Roberts M
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):121-8. PubMed ID: 12832115
[TBL] [Abstract][Full Text] [Related]
18. Expression of pertussis toxin in Bordetella bronchiseptica and Bordetella parapertussis carrying recombinant plasmids.
Lee CK; Roberts A; Perrin S
Infect Immun; 1989 May; 57(5):1413-8. PubMed ID: 2707851
[TBL] [Abstract][Full Text] [Related]
19. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children.
Mastrantonio P; Spigaglia P; Oirschot HV; van der Heide HGJ; Heuvelman K; Stefanelli P; Mooi FR
Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2069-2075. PubMed ID: 10463173
[TBL] [Abstract][Full Text] [Related]
20. Small mutations in Bordetella pertussis are associated with selective sweeps.
van Gent M; Bart MJ; van der Heide HG; Heuvelman KJ; Mooi FR
PLoS One; 2012; 7(9):e46407. PubMed ID: 23029513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
